JPH0533707B2 - - Google Patents
Info
- Publication number
- JPH0533707B2 JPH0533707B2 JP15244085A JP15244085A JPH0533707B2 JP H0533707 B2 JPH0533707 B2 JP H0533707B2 JP 15244085 A JP15244085 A JP 15244085A JP 15244085 A JP15244085 A JP 15244085A JP H0533707 B2 JPH0533707 B2 JP H0533707B2
- Authority
- JP
- Japan
- Prior art keywords
- cyanoquinuclidine
- solution
- added
- salt
- lithium
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- CEMKLAOKVLRABO-UHFFFAOYSA-N 1-azabicyclo[2.2.2]octane-4-carbonitrile Chemical compound C1CN2CCC1(C#N)CC2 CEMKLAOKVLRABO-UHFFFAOYSA-N 0.000 claims description 13
- 150000003839 salts Chemical class 0.000 claims description 8
- 150000001875 compounds Chemical class 0.000 claims description 7
- 238000004519 manufacturing process Methods 0.000 claims description 4
- 125000005843 halogen group Chemical group 0.000 claims description 3
- 239000000243 solution Substances 0.000 description 13
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 12
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 12
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 11
- 238000006243 chemical reaction Methods 0.000 description 7
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 6
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 6
- 238000000862 absorption spectrum Methods 0.000 description 6
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 6
- 229910000027 potassium carbonate Inorganic materials 0.000 description 6
- FVAUCKIRQBBSSJ-UHFFFAOYSA-M sodium iodide Chemical compound [Na+].[I-] FVAUCKIRQBBSSJ-UHFFFAOYSA-M 0.000 description 6
- 239000013078 crystal Substances 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- 238000002844 melting Methods 0.000 description 5
- 230000008018 melting Effects 0.000 description 5
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
- XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 description 4
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 4
- -1 inorganic acid salts Chemical class 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- UAOMVDZJSHZZME-UHFFFAOYSA-N diisopropylamine Chemical compound CC(C)NC(C)C UAOMVDZJSHZZME-UHFFFAOYSA-N 0.000 description 3
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 3
- IBYHHJPAARCAIE-UHFFFAOYSA-N 1-bromo-2-chloroethane Chemical compound ClCCBr IBYHHJPAARCAIE-UHFFFAOYSA-N 0.000 description 2
- LBLYYCQCTBFVLH-UHFFFAOYSA-M 2-methylbenzenesulfonate Chemical compound CC1=CC=CC=C1S([O-])(=O)=O LBLYYCQCTBFVLH-UHFFFAOYSA-M 0.000 description 2
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- MZRVEZGGRBJDDB-UHFFFAOYSA-N N-Butyllithium Chemical compound [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 description 2
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- DKGAVHZHDRPRBM-UHFFFAOYSA-N Tert-Butanol Chemical compound CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 description 2
- ZCSHNCUQKCANBX-UHFFFAOYSA-N lithium diisopropylamide Chemical compound [Li+].CC(C)[N-]C(C)C ZCSHNCUQKCANBX-UHFFFAOYSA-N 0.000 description 2
- KJIFKLIQANRMOU-UHFFFAOYSA-N oxidanium;4-methylbenzenesulfonate Chemical compound O.CC1=CC=C(S(O)(=O)=O)C=C1 KJIFKLIQANRMOU-UHFFFAOYSA-N 0.000 description 2
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 2
- ODZPKZBBUMBTMG-UHFFFAOYSA-N sodium amide Chemical compound [NH2-].[Na+] ODZPKZBBUMBTMG-UHFFFAOYSA-N 0.000 description 2
- 235000009518 sodium iodide Nutrition 0.000 description 2
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical class O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 2
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- YSLFXWOZZNHTEM-UHFFFAOYSA-N 1-(2-chloroethyl)piperidine-4-carbonitrile Chemical compound ClCCN1CCC(C#N)CC1 YSLFXWOZZNHTEM-UHFFFAOYSA-N 0.000 description 1
- OTZNTIOOWQUECP-UHFFFAOYSA-N 1-azabicyclo[2.2.2]octane-4-carbonitrile;4-methylbenzenesulfonic acid Chemical compound C1CN2CCC1(C#N)CC2.CC1=CC=C(S(O)(=O)=O)C=C1 OTZNTIOOWQUECP-UHFFFAOYSA-N 0.000 description 1
- HNAKTMSXYZOSTP-UHFFFAOYSA-N 1-methylpiperidine-4-carbonitrile Chemical compound CN1CCC(C#N)CC1 HNAKTMSXYZOSTP-UHFFFAOYSA-N 0.000 description 1
- BTVJTKWOCSGJDQ-UHFFFAOYSA-N 1-methylpiperidine-4-carboxamide Chemical compound CN1CCC(C(N)=O)CC1 BTVJTKWOCSGJDQ-UHFFFAOYSA-N 0.000 description 1
- ZFFBIQMNKOJDJE-UHFFFAOYSA-N 2-bromo-1,2-diphenylethanone Chemical compound C=1C=CC=CC=1C(Br)C(=O)C1=CC=CC=C1 ZFFBIQMNKOJDJE-UHFFFAOYSA-N 0.000 description 1
- SZIFAVKTNFCBPC-UHFFFAOYSA-N 2-chloroethanol Chemical compound OCCCl SZIFAVKTNFCBPC-UHFFFAOYSA-N 0.000 description 1
- DPBWFNDFMCCGGJ-UHFFFAOYSA-N 4-Piperidine carboxamide Chemical compound NC(=O)C1CCNCC1 DPBWFNDFMCCGGJ-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical group [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical group [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical compound Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 1
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 1
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 1
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- DTQVDTLACAAQTR-UHFFFAOYSA-M Trifluoroacetate Chemical compound [O-]C(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-M 0.000 description 1
- QQIRAVWVGBTHMJ-UHFFFAOYSA-N [dimethyl-(trimethylsilylamino)silyl]methane;lithium Chemical compound [Li].C[Si](C)(C)N[Si](C)(C)C QQIRAVWVGBTHMJ-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 229940024606 amino acid Drugs 0.000 description 1
- 229940009098 aspartate Drugs 0.000 description 1
- MWOBKFYERIDQSZ-UHFFFAOYSA-N benzene;sodium Chemical compound [Na].C1=CC=CC=C1 MWOBKFYERIDQSZ-UHFFFAOYSA-N 0.000 description 1
- SRSXLGNVWSONIS-UHFFFAOYSA-M benzenesulfonate Chemical compound [O-]S(=O)(=O)C1=CC=CC=C1 SRSXLGNVWSONIS-UHFFFAOYSA-M 0.000 description 1
- 229940077388 benzenesulfonate Drugs 0.000 description 1
- SHZJQHKVVLJYOD-UHFFFAOYSA-N benzhydrylbenzene;potassium Chemical compound [K].C1=CC=CC=C1C(C=1C=CC=CC=1)C1=CC=CC=C1 SHZJQHKVVLJYOD-UHFFFAOYSA-N 0.000 description 1
- GASBKMMGAZYXQD-UHFFFAOYSA-N benzhydrylbenzene;sodium Chemical compound [Na].C1=CC=CC=C1C(C=1C=CC=CC=1)C1=CC=CC=C1 GASBKMMGAZYXQD-UHFFFAOYSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 150000007942 carboxylates Chemical class 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000007810 chemical reaction solvent Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 125000001309 chloro group Chemical group Cl* 0.000 description 1
- WORJEOGGNQDSOE-UHFFFAOYSA-N chloroform;methanol Chemical compound OC.ClC(Cl)Cl WORJEOGGNQDSOE-UHFFFAOYSA-N 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000017858 demethylation Effects 0.000 description 1
- 238000010520 demethylation reaction Methods 0.000 description 1
- 229940043279 diisopropylamine Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 229930195712 glutamate Natural products 0.000 description 1
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 1
- 239000005457 ice water Substances 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 239000010410 layer Substances 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- AFRJJFRNGGLMDW-UHFFFAOYSA-N lithium amide Chemical compound [Li+].[NH2-] AFRJJFRNGGLMDW-UHFFFAOYSA-N 0.000 description 1
- 229910000103 lithium hydride Inorganic materials 0.000 description 1
- AHNJTQYTRPXLLG-UHFFFAOYSA-N lithium;diethylazanide Chemical compound [Li+].CC[N-]CC AHNJTQYTRPXLLG-UHFFFAOYSA-N 0.000 description 1
- 150000002688 maleic acid derivatives Chemical class 0.000 description 1
- 238000007069 methylation reaction Methods 0.000 description 1
- 239000012046 mixed solvent Substances 0.000 description 1
- 239000012044 organic layer Substances 0.000 description 1
- FSDNTQSJGHSJBG-UHFFFAOYSA-N piperidine-4-carbonitrile Chemical compound N#CC1CCNCC1 FSDNTQSJGHSJBG-UHFFFAOYSA-N 0.000 description 1
- NTTOTNSKUYCDAV-UHFFFAOYSA-N potassium hydride Chemical compound [KH] NTTOTNSKUYCDAV-UHFFFAOYSA-N 0.000 description 1
- 229910000105 potassium hydride Inorganic materials 0.000 description 1
- TYJJADVDDVDEDZ-UHFFFAOYSA-M potassium hydrogencarbonate Chemical compound [K+].OC([O-])=O TYJJADVDDVDEDZ-UHFFFAOYSA-M 0.000 description 1
- LPNYRYFBWFDTMA-UHFFFAOYSA-N potassium tert-butoxide Chemical compound [K+].CC(C)(C)[O-] LPNYRYFBWFDTMA-UHFFFAOYSA-N 0.000 description 1
- SBYHFKPVCBCYGV-UHFFFAOYSA-N quinuclidine Chemical compound C1CC2CCN1CC2 SBYHFKPVCBCYGV-UHFFFAOYSA-N 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 238000010898 silica gel chromatography Methods 0.000 description 1
- 239000012312 sodium hydride Substances 0.000 description 1
- 229910000104 sodium hydride Inorganic materials 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 150000003871 sulfonates Chemical class 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 229940095064 tartrate Drugs 0.000 description 1
- JOXIMZWYDAKGHI-UHFFFAOYSA-M toluene-4-sulfonate Chemical compound CC1=CC=C(S([O-])(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-M 0.000 description 1
- WTUYVMCQYIBIKQ-UHFFFAOYSA-K trilithium;trifluoride Chemical compound [Li+].[Li+].[Li+].[F-].[F-].[F-] WTUYVMCQYIBIKQ-UHFFFAOYSA-K 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000008096 xylene Substances 0.000 description 1
Landscapes
- Nitrogen Condensed Heterocyclic Rings (AREA)
Description
【発明の詳細な説明】
〔発明の目的〕
本発明は4−シアノキヌクリジンまたはその塩
の新規な製造方法に関するものである。DETAILED DESCRIPTION OF THE INVENTION [Object of the Invention] The present invention relates to a novel method for producing 4-cyanoquinuclidine or a salt thereof.
本発明化合物は医薬、化学試薬等の合成中間体
として有用であるが、その特異な構造より、その
合成は容易ではない。例えば、〔ヘルベチカ・キ
ミカ・アクタ(Helvetica chimica acta)第194
巻 第1672〜1679頁(1954年)〕および〔同195巻
第1680〜1680頁(1954年)〕にその合成例が報
告されている。同文献では、4−シアノキヌクリ
ジンは4−カルバモイルピペリジンを出発原料と
すると、N−メチル−4−カルバモイルピペリジ
ン、N−メチル−4−シアノピペリジン、N−メ
チル−4−シアノキヌクリジンを経由して合成さ
れているが、最初にN−メチル化し、最後に脱メ
チル化するため工程数が多いという点とピペリジ
ンからキヌクリジンへの変換工程の収率が17%と
低いという点に問題がある。 The compound of the present invention is useful as a synthetic intermediate for medicines, chemical reagents, etc., but its unique structure makes it difficult to synthesize. For example, [Helvetica chimica acta No. 194]
Examples of its synthesis are reported in Vol. 195, pp. 1672-1679 (1954) and Vol. 195, pp. 1680-1680 (1954). In the same document, 4-cyanoquinuclidine uses 4-carbamoylpiperidine as a starting material, and N-methyl-4-carbamoylpiperidine, N-methyl-4-cyanopiperidine, and N-methyl-4-cyanoquinuclidine. However, there are problems in that the number of steps is large because N-methylation is performed first and demethylation is performed last, and the yield of the conversion step from piperidine to quinuclidine is as low as 17%. be.
したがつて、本発明の目的は、工業的に優れた
4−シアノキヌクリジンまたはその塩の製造方法
を提供することにある。 Therefore, an object of the present invention is to provide an industrially excellent method for producing 4-cyanoquinuclidine or a salt thereof.
本発明は一般式:
〔式中、Xはハロゲン原子を示す〕で表わされ
る化合物またはその塩に塩基を反応させることを
特徴とする式:
で表わされる4−シアノキヌクリジンまたはその
塩の製造方法である。
The present invention has the general formula: A formula characterized by reacting a compound represented by [wherein X represents a halogen atom] or a salt thereof with a base: This is a method for producing 4-cyanoquinuclidine or a salt thereof represented by:
上記一般式()中のXのハロゲン原子として
は、塩素原子、臭素原子、沃素原子などがあげら
れる。また、一般式()および式()の化合
物の塩としては、塩酸塩、臭化水素酸塩、沃化水
素酸塩、硫酸塩、炭酸塩、重炭酸塩など無機酸
塩;酢酸塩、マレイン酸塩、乳酸塩、酒石酸塩、
トリフルオロ酢酸塩などの有機カルボン酸塩;メ
タンスルホン酸塩、ベンゼンスルホン酸塩、トル
エンスルホン酸塩などの有機スルホン酸塩;アス
パラギン酸塩、グルタミン酸塩などのアミノ酸塩
等があげられる。 Examples of the halogen atom for X in the above general formula () include a chlorine atom, a bromine atom, an iodine atom, and the like. In addition, salts of compounds of general formula () and formula () include inorganic acid salts such as hydrochloride, hydrobromide, hydroiodide, sulfate, carbonate, and bicarbonate; acetate, maleic acid salt, etc. acid salt, lactate, tartrate,
Examples include organic carboxylates such as trifluoroacetate; organic sulfonates such as methanesulfonate, benzenesulfonate, and toluenesulfonate; amino acid salts such as aspartate and glutamate.
本発明に用いられる塩基としては、ソデイウム
アミド、リチウムアミド、ポタシウムアミド、リ
チウムジイシプロピルアミド、リチウムジエチル
アミド、リチウムヘキサメチルジシラザン、ポタ
シウムt−ブトキサイド、ソデイウムハイドライ
ド、ポタシウムハイドライド、リチウムハイドラ
イド、リチウムトリフエニルメタン、ソデイウム
トリフエニルメタン、ポタシウムトリフエニルメ
タン、ソデイウムベンゼンなどがあげられる。 Examples of the base used in the present invention include sodium amide, lithium amide, potassium amide, lithium diisypropylamide, lithium diethylamide, lithium hexamethyldisilazane, potassium t-butoxide, sodium hydride, potassium hydride, lithium hydride, and lithium trifluoride. Examples include enylmethane, sodium triphenylmethane, potassium triphenylmethane, and sodium benzene.
本反応は−100℃〜溶媒還流温度で行なうこと
ができる。反応溶媒としては、1,2−ジメトキ
シエタン、テトラヒドロフラン、ジエチルエーテ
ル、ジオキサン、ベンゼン、キシレン、トルエ
ン、メタノール、エタノール、イソプロパノー
ル、n−プロパノール、n−ブタノール、t−ブ
タノール、ジメチルスルフオキシド、ジメチルホ
ルムアミド、液体アンモニアあるいはこれらの混
合溶媒があげられる。 This reaction can be carried out at -100°C to solvent reflux temperature. Reaction solvents include 1,2-dimethoxyethane, tetrahydrofuran, diethyl ether, dioxane, benzene, xylene, toluene, methanol, ethanol, isopropanol, n-propanol, n-butanol, t-butanol, dimethylsulfoxide, dimethylformamide. , liquid ammonia, or a mixed solvent thereof.
次に実験例および実施例を示し、本発明をさら
に詳しく説明する。 Next, the present invention will be explained in more detail by showing experimental examples and examples.
実験例 1
N−(2−ヒドロキシエチル)−4−カルバモイ
ルピペリジン
4−カルバモイルピペリジン35gのエタノール
500ml溶液に2−クロロエタノール23.9ml、炭酸
カリウム82.0gおよびヨウ化ナトリウム4.5gを
加え、20時間還流した。反応液を室温まで冷却し
た後、セライト過した。液を減圧濃縮し、残
渣を洗浄した後、乾燥して目的物46.6gを得た。Experimental example 1 N-(2-hydroxyethyl)-4-carbamoylpiperidine 4-carbamoylpiperidine 35g ethanol
23.9 ml of 2-chloroethanol, 82.0 g of potassium carbonate and 4.5 g of sodium iodide were added to the 500 ml solution, and the mixture was refluxed for 20 hours. After the reaction solution was cooled to room temperature, it was filtered through Celite. The liquid was concentrated under reduced pressure, and the residue was washed and dried to obtain 46.6 g of the target product.
融点:141〜142℃
赤外線吸収スペクトル(cm-1、ヌジヨール):
3360,3160,1650,1610
NMRスペクトル(δ,DMSO−d6):1.2〜2.1
(7H,m),2.26(2H,t,J=8Hz),2.6
〜2.9(2H,m),4.39(2H,t,J=8
Hz),4.32(1H,br.s),6.59(1H,br.s),
7.11(1H,br.s)
実験例 2
N−(2−クロロエチル)−4−シアノピペリジ
ン塩酸塩
実験例1の化合物38.7gのアセトニトリル390
ml懸濁液に、氷冷攪拌下、塩化チオニル82mlを1
時間かけて滴化した。得られた溶液を4時間還流
した後、濃縮した。残渣にイソプロパノール100
mlを加えて10分間還流した。溶液を室温にまで冷
却し、生じた結晶を取した。また、液にイソ
プロピルエーテルを加えて、生じた結晶を取し
た。無色結晶として、合計43.1gの目的物を得
た。 Melting point: 141-142℃ Infrared absorption spectrum (cm -1 , Nujiol):
3360, 3160, 1650, 1610 NMR spectrum (δ, DMSO- d6 ): 1.2-2.1
(7H, m), 2.26 (2H, t, J=8Hz), 2.6
~2.9 (2H, m), 4.39 (2H, t, J=8
Hz), 4.32 (1H, br.s), 6.59 (1H, br.s),
7.11 (1H, br.s) Experimental example 2 N-(2-chloroethyl)-4-cyanopiperidine hydrochloride Acetonitrile 390 of 38.7 g of the compound of Experimental Example 1
ml suspension, add 1 82 ml of thionyl chloride under ice-cooling and stirring.
It took a while to form into drops. The resulting solution was refluxed for 4 hours and then concentrated. Isopropanol 100 to the residue
ml and refluxed for 10 minutes. The solution was cooled to room temperature and the resulting crystals were collected. Further, isopropyl ether was added to the liquid and the resulting crystals were collected. A total of 43.1 g of the target product was obtained as colorless crystals.
融点:176〜178℃
赤外線吸収スペクトル(cm-1、ヌジヨール):
2220
NMRスペクトル(δ,DMSO−d6):1.7〜2.3
(4H,m),2.6〜3.8(7H,m),3.98(2H,
t,J=8Hz)
実験例 3
N−(2−クロロエチル)−4−シアノピペリジ
ン
4−シアノピペリジン2.63gのイソプロパノー
ル50ml溶液に1−ブロモ−2−クロロエタン2.6
mlおよび炭酸カリウム6.6gを加え、10時間還流
した。反応液を減圧濃縮し、残渣に50%炭酸カリ
ウム水溶液を加えた後、ジエチルエーテルで抽出
した。抽出液を飽和食塩水で洗浄し、無水炭酸カ
リウムを加えて乾燥後、減圧濃縮した。残渣をシ
リカゲルカラムクロマトグラフイー(展開溶媒:
メタノール−クロロホルム)にて精製して油状の
目的物0.31gを得た。 Melting point: 176-178℃ Infrared absorption spectrum (cm -1 , Nujiol):
2220 NMR spectrum (δ, DMSO- d6 ): 1.7-2.3
(4H, m), 2.6-3.8 (7H, m), 3.98 (2H,
t, J=8Hz) Experimental example 3 N-(2-chloroethyl)-4-cyanopiperidine A solution of 2.63 g of 4-cyanopiperidine in 50 ml of isopropanol and 2.6 g of 1-bromo-2-chloroethane
ml and 6.6 g of potassium carbonate were added, and the mixture was refluxed for 10 hours. The reaction solution was concentrated under reduced pressure, and a 50% aqueous potassium carbonate solution was added to the residue, followed by extraction with diethyl ether. The extract was washed with saturated brine, dried over anhydrous potassium carbonate, and concentrated under reduced pressure. The residue was subjected to silica gel column chromatography (developing solvent:
The product was purified using methanol-chloroform) to obtain 0.31 g of the target product as an oil.
赤外線吸収スペクトル(cm-1、ニート):2220
NMRスペクトル(δ,CDCl3):1.7〜2.1(4H,
m),2.3〜2.9(7H,m),3.56(2H,t,
J=8Hz)
実施例 1
4−シアノキヌクリジンおよびそのP−トルエ
ンスルホン酸塩
ソデイウムアミド150gおよびヨウ化ナトリウ
ム7.2gを1,2−ジメトキシエタン1.5に懸濁
し、室温で1時間攪拌した。これに実験例2の化
合物100gを加え24時間攪拌した。反応液を氷水
2中に加え、セライト過した。残渣をジエチ
ルエーテル300mlで洗浄した。前記液の有機層
とこの洗浄液を合わせ、無水炭酸カリウムを加え
て乾燥した。これを濃縮して4−シアノキヌクリ
ジン78.7gを得た。さらに前記液の水層に無水
炭酸カリウム1Kgを加えた後、クロロホルムで抽
出した。抽出液に無水炭酸カリウムを加えて乾燥
後、濃縮して4−シアノキヌクリジン18.9gを得
た。合計4−シアノキヌクリジン97.6g(収率
66.3%)を得た。 Infrared absorption spectrum (cm -1 , neat): 2220 NMR spectrum (δ, CDCl 3 ): 1.7-2.1 (4H,
m), 2.3-2.9 (7H, m), 3.56 (2H, t,
J=8Hz) Example 1 4-cyanoquinuclidine and its P-toluenesulfonate 150 g of sodium amide and 7.2 g of sodium iodide were suspended in 1.5 g of 1,2-dimethoxyethane and stirred at room temperature for 1 hour. 100 g of the compound of Experimental Example 2 was added to this and stirred for 24 hours. The reaction solution was added to ice water 2 and filtered through Celite. The residue was washed with 300 ml of diethyl ether. The organic layer of the above liquid and this washing liquid were combined and dried by adding anhydrous potassium carbonate. This was concentrated to obtain 78.7 g of 4-cyanoquinuclidine. Further, 1 kg of anhydrous potassium carbonate was added to the aqueous layer of the liquid, and then extracted with chloroform. The extract was dried by adding anhydrous potassium carbonate and concentrated to obtain 18.9 g of 4-cyanoquinuclidine. Total 4-cyanoquinuclidine 97.6g (yield
66.3%).
4−シアノキヌクリジン85.0gをエタノール
200mlに懸濁し、p−トルエンスルホン酸・一水
和物119gのエタノール350ml溶液を加え、40℃で
1時間攪拌した。反応液を氷冷し、析出した結晶
を取した。これをエタノールおよびジエチルエ
ーテルで洗浄し、4−シアノキヌクリジン p−
トルエンスルホン酸塩の無色結晶182.9g(収率
95%)を得た。 85.0g of 4-cyanoquinuclidine in ethanol
A solution of 119 g of p-toluenesulfonic acid monohydrate in 350 ml of ethanol was added, and the mixture was stirred at 40°C for 1 hour. The reaction solution was cooled with ice, and the precipitated crystals were collected. This was washed with ethanol and diethyl ether, and 4-cyanoquinuclidine p-
182.9g of colorless crystals of toluenesulfonate (yield
95%).
4−シアノキヌクリジン
融点:133℃
赤外線吸収スペクトル(cm-1、ヌジヨール):
2225
NMRスペクトル(δ,CDCl3):1.6〜2.0(6H,
m),2.7〜3.0(6H,m)
4−シアノキヌクリジン p−トルエンスルホン
酸塩
融点:220℃以上
赤外線吸収スペクトル(cm-1,ヌジヨール):
2220
NMRスペクトル(δ,DMSO−d6):2.0〜2.3
(6H,m),2.27(3H,s),3.1〜3.5(6H,
m),7.08(2H,d,J=10Hz),7.45(2H,
d,J=10Hz)
実施例 2
4−シアノキヌクリジン
ジイソプロピルアミン4.7mlのテトラヒドロフ
ラン70ml溶液に−78℃でn−ブチルリチウム19.9
mlを加え10分間攪拌した。得られたリチウムジイ
ソプロピルアミド溶液に、同温度で実験例3の化
合物5.0gのテトラヒドロフラン30ml溶液を10分
間かけて滴下した。同温度で20分間攪拌した後、
さらに0℃で30分間攪拌した。反応液を飽和食塩
水で洗浄した後、クロロホルムで抽出した。抽出
液を濃縮し、残渣を昇華して目的物2.6g(収率
65.3%)を得た。 4-Cyanoquinuclidine Melting point: 133°C Infrared absorption spectrum (cm -1 , Nudiol):
2225 NMR spectrum (δ, CDCl3 ): 1.6-2.0 (6H,
m), 2.7 to 3.0 (6H, m) 4-cyanoquinuclidine p-toluenesulfonate Melting point: 220°C or higher Infrared absorption spectrum (cm -1 , Nudiol):
2220 NMR spectrum (δ, DMSO- d6 ): 2.0-2.3
(6H, m), 2.27 (3H, s), 3.1~3.5 (6H,
m), 7.08 (2H, d, J=10Hz), 7.45 (2H,
d, J = 10Hz) Example 2 4-cyanoquinuclidine n-Butyllithium 19.9% in a solution of 4.7ml diisopropylamine in 70ml tetrahydrofuran at -78°C.
ml was added and stirred for 10 minutes. A solution of 5.0 g of the compound of Experimental Example 3 in 30 ml of tetrahydrofuran was added dropwise to the obtained lithium diisopropylamide solution over 10 minutes at the same temperature. After stirring at the same temperature for 20 minutes,
The mixture was further stirred at 0°C for 30 minutes. The reaction solution was washed with saturated brine and then extracted with chloroform. The extract was concentrated and the residue was sublimated to obtain 2.6 g of the target product (yield:
65.3%).
融点:133℃
赤外線吸収スペクトル(cm-1、ヌジヨール):
2225
NMRスペクトル(δ,CDCl3):1.6〜2.0(6H,
m),2.7〜3.0(6H,m) Melting point: 133°C Infrared absorption spectrum (cm -1 , Nujiol):
2225 NMR spectrum (δ, CDCl3 ): 1.6-2.0 (6H,
m), 2.7-3.0 (6H, m)
Claims (1)
る化合物またはその塩に塩基を反応させることを
特徴とする式: で表わされる4−シアノキヌクリジンまたはその
塩の製造方法。[Claims] 1. General formula: A formula characterized by reacting a compound represented by [wherein X represents a halogen atom] or a salt thereof with a base: A method for producing 4-cyanoquinuclidine or a salt thereof represented by:
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP15244085A JPS6216481A (en) | 1985-07-12 | 1985-07-12 | Production of 4-cyanoquinuclidine |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP15244085A JPS6216481A (en) | 1985-07-12 | 1985-07-12 | Production of 4-cyanoquinuclidine |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS6216481A JPS6216481A (en) | 1987-01-24 |
| JPH0533707B2 true JPH0533707B2 (en) | 1993-05-20 |
Family
ID=15540577
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP15244085A Granted JPS6216481A (en) | 1985-07-12 | 1985-07-12 | Production of 4-cyanoquinuclidine |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS6216481A (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6431966A (en) * | 1987-07-25 | 1989-02-02 | Tokin Corp | Alloy target material and its production |
-
1985
- 1985-07-12 JP JP15244085A patent/JPS6216481A/en active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| JPS6216481A (en) | 1987-01-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2669701C2 (en) | Piperidine derivatives as orexin receptor antagonists | |
| NO151876B (en) | PROCEDURE AND APPARATUS FOR ANIMAL LINING | |
| US10040764B2 (en) | Processes for the preparation of 4-alkoxy-3-(acyl or alkyl)oxypicolinamdes | |
| TWI343909B (en) | Process for making galantamine | |
| KR20190044652A (en) | Method for producing indolecarboxamide compound | |
| NO328154B1 (en) | Technical synthesis method for the preparation of Tropenol and the use of such compounds for the preparation of therapeutically active compounds | |
| CN106111190A (en) | A kind of chirality biaryl skeleton pyridoxamine class catalyst and synthetic method thereof and application | |
| JPH0533707B2 (en) | ||
| EP0213337B1 (en) | 4-cyanopiperidine derivatives, preparation and use thereof | |
| CN102216274A (en) | Process for making (r) -3-(2,3-dihydroxypropyl)-6-fluoro-5-(2-flouro-4-iodophenylamino)-8-methylpyrido[2,3-d]pyrimidine-4,7(3h,8h)-dione and intermediates thereof | |
| JP3091006B2 (en) | Synthesis of 1,2,3-oxathiazolidine derivatives and thieno [3,2-c] pyridine derivatives | |
| CN109195954A (en) | The chiral resolution and its eutectic of the intermediate of Wo Leisheng | |
| JP3207018B2 (en) | Method for producing benzylsuccinic acid derivative and intermediate for producing the same | |
| JPS6148839B2 (en) | ||
| JPH085876B2 (en) | Method for synthesizing 4-cyanoquinuclidine | |
| CA2287566A1 (en) | 9,10-diazatricyclo¬4.2.1.12,5|decane and 9,10-diazatricyclo¬3.3.1.12,6|decane derivatives having analgesic activity | |
| US6388083B2 (en) | Process for the synthesis of (2S)-phenyl-3-piperidone | |
| JP2000007664A (en) | Optically active piperazine compound, its intermediate and their production | |
| JP2007502311A (en) | Synthesis of heterocyclic compounds | |
| US3751462A (en) | Process for preparation of substituted fluoromethanesulfonanilides | |
| JP4571505B2 (en) | Process for producing 1- [2- (benzimidazol-2-ylthio) ethyl] piperazine or a salt thereof | |
| JPH01199968A (en) | Production of 4-cyanoquinuclidine | |
| JPH06741B2 (en) | Method for producing indoles | |
| JPH05221947A (en) | Production of cyclopropane derivative | |
| JP2017513943A (en) | Novel production method of amorphous raloxifene hydrochloride and novel intermediate used in the same |